Comparing public policies impacting prescribing and medication management in primary care in two Canadian provinces.


Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
09 2021
Historique:
received: 21 12 2020
revised: 13 05 2021
accepted: 04 06 2021
pubmed: 29 6 2021
medline: 1 2 2022
entrez: 28 6 2021
Statut: ppublish

Résumé

The challenges of polypharmacy and inappropriate prescribing are recognized internationally. This study synthesizes and compares the policies related to these issues introduced in Canada's two most populous provinces - Ontario and Quebec - over the first two decades of the 21st century. Drawing on policy documents and consultations with experts, we found that while medication management to address polypharmacy and inappropriate prescribing has not been an explicit and consistent policy target in either province, some policy changes sought to directly or indirectly impact medication management. These changes include the introduction of primary care teams that include pharmacists, the introduction of a medication review performed by pharmacists (in Ontario), increased emphasis on quality improvement with some attention to potentially inappropriate medications (specifically opioids in Ontario), and investments in information technology to improve communication across providers and move toward electronic prescribing to improve medication safety and appropriateness. Despite growing evidence of the problem of polypharmacy and inappropriate prescribing, there has been limited policy attention targeting these problems directly, and policy changes with potential to improve prescribing and medication management may not have been fully realized. Further research to evaluate the impact of these changes on provider behaviours, and on patient outcomes, warrants attention.

Identifiants

pubmed: 34176672
pii: S0168-8510(21)00159-7
doi: 10.1016/j.healthpol.2021.06.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1121-1130

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts to declare.

Auteurs

Sara Allin (S)

Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College St 4th Floor, Toronto, ON M5T 3M6, Canada. Electronic address: Sara.allin@utoronto.ca.

Elisabeth Martin (E)

Faculté des sciences infirmières, Université Laval, Pavillon Ferdinand-Vandry, 1050, avenue de la Médecine - local 3645 Québec (Québec), G1V 0A6, Canada. Electronic address: elisabeth.martin@fsi.ulaval.ca.

David Rudoler (D)

Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College St 4th Floor, Toronto, ON M5T 3M6, Canada; Faculty of Health Sciences, Ontario Tech University, 2000 Simcoe St N, Oshawa, ON L1G 0C5, Canada. Electronic address: David.Rudoler@ontariotechu.ca.

Michael Church Carson (M)

Department of Economics and Department of Epidemiology, Biostatistics and Occupational Health, McGill University Leacock Building, Room 418 855 Sherbrooke Street West, Montreal, QC H3A 2T7, Canada. Electronic address: michael.churchcarson@mail.mcgill.ca.

Agnes Grudniewicz (A)

Telfer School of Management / École de gestion Telfer, University of Ottawa / Université d'Ottawa, 55 Laurier Ave. E, Ottawa, ON K1N 6N5, Canada. Electronic address: grudniewicz@telfer.uottawa.ca.

Sydney Jopling (S)

Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College St 4th Floor, Toronto, ON M5T 3M6, Canada.

Erin Strumpf (E)

Department of Economics and Department of Epidemiology, Biostatistics and Occupational Health, McGill University Leacock Building, Room 418 855 Sherbrooke Street West, Montreal, QC H3A 2T7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH